New: NCI-funded clinical trial search
Mednet Logo
CommunityHematology

Hematology

Clinical discussions on blood disorders, coagulation, transfusion medicine, and hematologic malignancies.

Recent Discussions

What is your approach for bulky stage I primary mediastinal B-cell lymphoma in a patient with a positive post-chemotherapy PET-CT (residual mass and Deauville 5)?

2
2 Answers

Mednet MemberInvited Expert
Medical Oncology · Rutgers Cancer Institute of New Jersey

Interpreting end-of-treatment PET in PMBL can be tricky. False positives here are very common! Fake-outs include thymic rebound masquerading as refractory disease; avidity at rim (which is almost always biopsy-neg); or residual avidity throughout residual mass which again can be biopsy negative. I w...

Does aspirin dose (81 mg vs 325 mg) matter for secondary stroke prevention?

3
1 Answers

Mednet MemberInvited Expert
Neurology · HCA Houston Healthcare

This topic has been debated extensively. There are two camps in this debate: Aspirin with a dose of 81 mg is adequate for platelet inhibition in the general population. Aspirin with a dose of 325 mg may be needed for individuals who weigh more (>70 kg) to achieve appropriate platelet inhibition. T...

Are you including Bortezomib as standard of care in the upfront treatment of T lymphoblastic-lymphoma?

1 Answers

Mednet MemberInvited Expert
Pediatric Hematology/Oncology · Emory University

We do use bortezomib in the upfront treatment of T-cell lymphoblastic lymphoma in children and AYA. For those familiar with the topic, the results of two successive large clinical trials in T-LLy done by COG, AALL0434, and AALL1231, were confusing. Due to the rarity of the disease, overlapping trial...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

Is there any indication for hydroxyurea in patients with sickle cell trait?

1
2 Answers

Mednet MemberInvited Expert
Pediatric Hematology/Oncology · FibroFighters Foundation

No. Of course, be sure it is the correct diagnosis and not HgA + HgS (beta+) which, as you know, shows HgA and HgS on electrophoresis and can/will be called trait if not looked at by someone experienced to note if A> S or if S > A. If MCV is low. If HgA2 is up. HgF up etc... If indirect Bili/LDH/AST...

Would you start anticoagulation in a patient with provoked blood clot in the past now with labs done for rheumatological reasons showing triple positive APLA?

3
3 Answers

Mednet MemberInvited Expert
Rheumatology · Hackensack University Medical Center

The short answer is that I would probably not anticoagulate this patient as a history of prior thrombosis is hard to connect to the currently positive APL antibodies. I would certainly obtain a second set for future risk stratification. However, there are several variables that could influence the ...

How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?

1 Answers

Mednet MemberInvited Expert
Pediatric Hematology/Oncology · Weill Cornell Medical College

The precise pathophysiology of deferiprone associated arthropathy is not well understood but some reports have suggested that there may be some deposition of iron in the synovial membranes, and some subchondral bone damage. Unfortunately, there is no specific treatment for this arthritis, other than...

What workup do you perform for elevated B12 levels in an adult who is not taking supplements?

1
1 Answers

Mednet MemberInvited Expert
Hematology · Weill Cornell Medical College and Houston Methodist Hospital

There is no convincing evidence of the harmful effects of elevated serum B12 per se, so I have not vigorously pursued this lab finding. If excessive supplements are consumed, B12 is innocuously excreted in the urine once tissue receptors are saturated. Nonetheless, this question raises some interest...

How do you manage mild Type 1 von Willebrand disease undergoing wisdom teeth removal?

1
1 Answers

Mednet MemberInvited Expert
Hematology · Former Assistant Chief of the Hematology Branch

This depends on the patient's past personal and family bleeding history with past challenges and on the VWF levels. If past challenges are known and no bleeding has occurred, and if the VWF levels are 30 IU/dL or greater, I would give only EACA p.o. pre and post. Intranasal DDAVP 2 hours prior and 4...

Is there a correlation between spleen size and degree of thrombocytopenia?

1
1 Answers

Mednet MemberInvited Expert
Hematology · University of Washington

In a normal individual, approximately 1/3 of total body platelets are sequestered in the spleen at any given time. As the size of the spleen increases, so too does the proportion of platelets in the spleen increase. This is due to the total volume of the spleen, not just longitudinal measurement. It...

Would you consider continuing or re-trialing hydroxyurea for sickle cell patients after development of a leg ulcer?

1 Answers

Mednet MemberInvited Expert
Pediatric Hematology/Oncology · FibroFighters Foundation

I do not think HU is the cause of leg ulcers, neither does ASJ. Habibi et al., Blood 2023 Most cases of ulcers are multifactorial and studies have also included patients with thrombocytosis (even myeloproliferative disorders!!). Low nitric oxide is part of the cause of leg ulcers in most cases. HU r...